JP2005504847A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504847A5
JP2005504847A5 JP2003534430A JP2003534430A JP2005504847A5 JP 2005504847 A5 JP2005504847 A5 JP 2005504847A5 JP 2003534430 A JP2003534430 A JP 2003534430A JP 2003534430 A JP2003534430 A JP 2003534430A JP 2005504847 A5 JP2005504847 A5 JP 2005504847A5
Authority
JP
Japan
Prior art keywords
triazafluoren
acid
valeric acid
methylenedioxybenzylamino
benzylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003534430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504847A (ja
JP4782376B2 (ja
Filing date
Publication date
Priority claimed from DE10148883A external-priority patent/DE10148883A1/de
Application filed filed Critical
Publication of JP2005504847A publication Critical patent/JP2005504847A/ja
Publication of JP2005504847A5 publication Critical patent/JP2005504847A5/ja
Application granted granted Critical
Publication of JP4782376B2 publication Critical patent/JP4782376B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003534430A 2001-10-04 2002-09-05 ピリミジン誘導体 Expired - Fee Related JP4782376B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10148883A DE10148883A1 (de) 2001-10-04 2001-10-04 Pyrimidinderivate
DE10148883.1 2001-10-04
PCT/EP2002/009935 WO2003031447A2 (de) 2001-10-04 2002-09-05 Pyrimidinderivate mit pde-v hemmender wirkung

Publications (3)

Publication Number Publication Date
JP2005504847A JP2005504847A (ja) 2005-02-17
JP2005504847A5 true JP2005504847A5 (enExample) 2006-01-05
JP4782376B2 JP4782376B2 (ja) 2011-09-28

Family

ID=7701322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003534430A Expired - Fee Related JP4782376B2 (ja) 2001-10-04 2002-09-05 ピリミジン誘導体

Country Status (16)

Country Link
US (1) US7312224B2 (enExample)
EP (1) EP1432715B1 (enExample)
JP (1) JP4782376B2 (enExample)
KR (1) KR20040041166A (enExample)
CN (1) CN1863803A (enExample)
AT (1) ATE389655T1 (enExample)
AU (1) AU2002362806B2 (enExample)
BR (1) BR0213037A (enExample)
CA (1) CA2462799C (enExample)
DE (2) DE10148883A1 (enExample)
ES (1) ES2303564T3 (enExample)
HU (1) HUP0401654A3 (enExample)
PL (1) PL369819A1 (enExample)
RU (1) RU2004114239A (enExample)
WO (1) WO2003031447A2 (enExample)
ZA (1) ZA200403334B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005061170A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
DE102005061171A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
AR062501A1 (es) * 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
AR064155A1 (es) * 2006-12-07 2009-03-18 Piramed Ltd Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
DE102007027799A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007027800A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
DE102007051762A1 (de) * 2007-10-30 2009-05-07 Bayer Healthcare Ag Substituierte Pyrrolotriazine und ihre Verwendung
DE102007054786A1 (de) * 2007-11-16 2009-05-20 Bayer Healthcare Ag Trisubstituierte Furopyrimidine und ihre Verwendung
WO2011143607A1 (en) * 2010-05-14 2011-11-17 The Regents Of The University Of California Modulation of bioactive epoxy-fatty acid levels by phosphodiesterase inhibitors
WO2012012712A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Tricyclic proteasome activity enhancing compounds
WO2013112651A2 (en) 2012-01-25 2013-08-01 Proteostasis Therapeutics, Inc. Proteasome activity modulating compounds
EP3194399B1 (en) 2014-09-17 2019-04-10 Pécsi Tudományegyetem New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
WO2016133788A1 (en) 2015-02-20 2016-08-25 The Regents Of The University Of California Methods of inhibiting pain
WO2017092523A1 (zh) * 2015-12-02 2017-06-08 深圳市塔吉瑞生物医药有限公司 一种稠合嘧啶化合物及包含该化合物的组合物及其用途
CN105461728A (zh) * 2015-12-29 2016-04-06 中山大学 一种4-取代胺基-6-甲氧羰基苯并呋喃并[2,3-d]嘧啶类化合物及制备方法
RU2625316C1 (ru) * 2016-04-13 2017-07-13 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 2-АМИНОЗАМЕЩЕННЫЕ 6-МЕТОКСИ-4-ТРИФТОРМЕТИЛ-9Н-ПИРИМИДО[4,5b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ПРЕДШЕСТВЕННИКИ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037980A (en) * 1955-08-18 1962-06-05 Burroughs Wellcome Co Pyrrolopyrimidine vasodilators and method of making them
GB915304A (en) * 1958-03-13 1963-01-09 Wellcome Found Pyrrolo[2,3-d]pyrimidine derivatives
JPS5542999B2 (enExample) * 1972-02-14 1980-11-04
CH592668A5 (enExample) 1973-10-02 1977-10-31 Delalande Sa
US4487626A (en) 1980-08-22 1984-12-11 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
ZA815765B (en) * 1980-08-22 1983-04-27 Du Pont Herbicidal sulfonamides
JP2562520B2 (ja) * 1989-09-19 1996-12-11 帝人株式会社 ピロロ〔2,3ーd〕ピリミジン誘導体、その製造方法およびそれを有効成分とする医薬製剤
EP0514540B1 (en) 1989-09-19 1996-07-17 Teijin Limited PYRROLO 2,3-d]PYRIMIDINE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATION COMPRISING THE DERIVATIVE AS ACTIVE INGREDIENT
US5869486A (en) 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
JP4611524B2 (ja) 1998-06-02 2011-01-12 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド ピロロ[2,3d]ピリミジン組成物およびその使用
DE19942474A1 (de) 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
DE19944604A1 (de) 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
DK1246623T3 (da) 1999-12-02 2006-11-13 Osi Pharm Inc Forbindelser, som er specifikke for adenosin A1-, A2a- og A3-receptor og anvendelser deraf
EA007254B1 (ru) 2000-12-01 2006-08-25 Оси Фармасьютикалз, Инк. Соединения, специфические к аденозиновому а, аи арецептору, и их применение

Similar Documents

Publication Publication Date Title
JP2005504847A5 (enExample)
NO2017051I1 (no) Kariprazin, eventuelt i form av et salt, inkludert kariprazin hydroklorid
NO2014005I1 (no) olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav
AU2003303199A1 (en) Generation of efficacy, toxicity and disease signatures and methods of use thereof
AU2003303201A1 (en) Multipurpose brush
WO2003012908A8 (en) Battery structures, self-organizing structures and related methods
JP2004538039A5 (enExample)
ITMI20020598A0 (it) Fluoroelastomeri vulcanizzabili
AU2003273474A1 (en) Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy
DK1530466T3 (da) Anvendelse af nintedanib til behandling af lungefibrose
AU2003286374A1 (en) Effective point coordination function in wireless lan
JP2004514064A5 (enExample)
WO2004046981A8 (en) Public sector value model
AU2003234796A1 (en) Diimonium salt mixtures, aminium salts mixtures and use thereof
AU2003277215A1 (en) Novel neurokinin antagonists and methods of use thereof
EP1673384A4 (en) NITROSED GLUTAMIC ACID COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE
WO2003063576A3 (en) Arylsulfonamidobenzylic compounds
AU2003245455A1 (en) Hammerhead ribozymes
JP2003245242A5 (enExample)
AU2003266142A1 (en) Mucus formulation for mucosal surfaces and uses thereof
AU2003217339A1 (en) Retail lending risk related scenario generation
AU2003244922A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
AU2003280143A1 (en) N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
AU2003259734A1 (en) Flat heat brush
AU2003247239A1 (en) Wooden dumbbell